Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers - I: Formulation, lyoavailability and in vitro antimalarial activity assessment

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 3, 2012, Pages 508-517

  Yaméogo, Josias B G ^a,c   Gze, Annabelle ^a   Choisnard, Luc ^a   Putaux, Jean Luc ^b   Gansané, Adama ^d   Sirima, Sodiomon B ^d   Semdé, Rasmané ^c   Wouessidjewe, Denis ^a  

^a UNIV GRENOBLE ALPES   (France)

^b CENTRE DE RECHERCHES SUR LES MACROMOLÉCULES VÉGÉTALES CERMAV CNRS   (France)

^c UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^d Burkina Faso   (Burkina Faso)

Author keywords

Amphiphilic cyclodextrins; Artemisinin; Cryo TEM; Malaria; Nanocarriers; Plasmodium falciparum

Indexed keywords

AMPHOPHILE; ARTEMISININ; BETA CYCLODEXTRIN; CYCLODEXTRIN; DECANOIC ACID; ESTER DERIVATIVE; GAMMA CYCLODEXTRIN; LACTATE DEHYDROGENASE; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; NANOSPHERE; UNCLASSIFIED DRUG; VINYL ACYL FATTY ESTER;

ANTIMALARIAL ACTIVITY; ARTICLE; BIOCATALYSIS; DRUG FORMULATION; DRUG RELEASE; GROWTH INHIBITION; IC 50; IN VITRO STUDY; NONHUMAN; PHYSICAL CHEMISTRY; PLASMODIUM FALCIPARUM; TRANSESTERIFICATION;

ANTIMALARIALS; ARTEMISININS; CHEMISTRY, PHARMACEUTICAL; COLLOIDS; CYCLODEXTRINS; DRUG CARRIERS; NANOPARTICLES; NANOSTRUCTURES; PARTICLE SIZE; PLASMODIUM FALCIPARUM; POLYETHYLENE GLYCOLS; SOLVENTS; SURFACE-ACTIVE AGENTS; SUSPENSIONS;

EID: 84858155524     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.12.007     Document Type: Article

References (36)

1. World Health Organization (WHO), Management of Severe Malaria: A Practical Handbook, second ed., 2000, 84p.
2. M.E. Van Agtmael, T.A. Eggelte, and C.J. van Boxtel Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication TiPS 20 1999 199 205
3. J.F.S. Ferreira, J. C Laughlin, N. Delabays, and P.M. Magalhaes Cultivation and genetics of Artemisia annua for increased production of the anti-malarial artemisinin Plant Genet. Resour. 3 2005 206 229 (Pubitemid 41391570)
4. J.W. Wong, and K.H. Yuen Inclusion complexation of artemisinin with α-, β- and γ-cyclodextrins Drug Dev. Ind. Pharm. 29 2003 1035 1044
5. J.W. Wong, and K.H. Yuen Improved oral bioavailability of artemisinin through inclusion complexation β- and γ-cyclodextrins Int. J. Pharm. 227 2001 177 185 (Pubitemid 32868771)
6. N.G. Sahoo, A. Abbas, Z. Judeh, C.M. Li, and K.-H. Yuen Solubility enhancement of poorly water-soluble antimalarial drug: experimental design and use of a modified multifluid nozzle pilot spray drier J. Pharm. Sci. 98 1 2009 281 296
7. B. Chimanuka, M. Gabriels, M.-R. Dtaevernier, and J.A. Plaizier-Vercammen Preparation of β-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitemia in Plasmodium chabaudi malaria-infected mice J. Pharmaceut. Biomed. Anal. 28 2002 13 22 (Pubitemid 34171642)
8. M. Gabriels Physical and chemical evaluation of liposomes, containing artesunate J. Pharm. Biomed. Anal. 31 2003 655 667 (Pubitemid 36315707)
9. M. Owais, G.C. Varshney, A. Choudhury, S. Chandra, and C.M. Gupta Chloroquine encapsulated in malaria-infected erythrocytes-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice Antimicrob. Agents Chemother. 39 1995 180 184
10. V.C.F. Mosqueira, P.M. Loiseau, C. Bories, P. Legrand, J.-P. Devissaguet, and G. Barrat Efficacy and pharmacokinetics of intravenous nanocapsules formulations of halofantrine in Plasmodium berghei-infected mice Antimicrob. Agents Chemother. 48 2004 1222 1228 (Pubitemid 38405476)
11. L. Choisnard, A. Gze, B.G.J. Yaméogo, J.-L. Putaux, and D. Wouessidjewe Miscellaneous nanoaggregates made of CD esters synthesised by an enzymatic pathway Int. J. Pharm. 344 2007 26 32 (Pubitemid 47464829)
12. L. Choisnard, A. Gze, J.-L. Putaux, Y.S. Wong, and D. Wouessidjewe Novel nanoparticles of β-cyclodextrin esters obtained by self-assembling of bio-transesterified β-cyclodextrins Biomacromolecules 7 2006 515 520
13. A. Gze, L. Choisnard, J.-L. Putaux, and D. Wouessidjewe Colloidal systems made of biotransesterified cyclodextrins grafted with C10 alkyl chains Mater. Sci. Eng. C 29 2009 458 462
14. O. Arnaud, A. Boumendjel, A. Gze, M. Honorat, E.L. Matera, J. Guitton, W.D. Stein, S.E. Bates, P. Falson, C. Dumontet, A. Di Pietro, and L. Payen The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan Eur. J. Cancer 47 2011 640 648
15. L. Choisnard, A. Gze, C. Vanharverbeke, J.B.G. Yaméogo, J.-L. Putaux, B. Brasme, L. Julien, S. Boulanger, C. Elfakir, and D. Wouessidjewe Physicochemical characterization of α-, β- and γ-cyclodextrins bioesterified with decanoate chains used as building blocks of colloidal nanoparticles Biomacromolecules 12 8 2011 3031 3038
16. S.S. Zhao High-performance liquid chromatographic determination of artemisinin (qinghaosu) in human plasma and saliva Analyst 112 1987 661 664
17. A. Gze, J.-L. Putaux, L. Choisnard, P. Jehan, and D. Wouessidjewe Long-term shelf stability of amphiphilic beta-cyclodextrin nanosphere suspensions monitored by dynamic light scattering and cryo-transmission electron microscopy J. Microencapsul. 21 6 2004 607 613 (Pubitemid 40069055)
18. B.A. Avery, K.K. Venkatesh, and M. A Avery Rapid determination of artemisinin and related analogues using high-performance liquid chromatography and an evaporative light scattering detector J. Chromatogr. B 730 1999 71 80 (Pubitemid 29290608)
19. A. Gansané, S. Sanon, L.P. Ouattara, A. Traoré, S. Hutter, E. Olivier, N. Azas, S. Traoré, I.P. Guissou, S.B. Sirima, and I. Nebié Antiplasmodial activity and toxicity of crude extracts from alternatives parts of plants widely used for the treatment of malaria in Burkina Faso: contribution for their preservation Parasitol. Res. 106 2010 335 340
20. P. Druilhe, A. Moreno, C. Blanc, P.H. Brasseur, and P. Jacquier A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay Am. J. Trop. Med. Hyg. 64 5,6 2001 233 241
21. E. Fattoruso, S. Parapini, C. Campagnuolo, N. Basilico, O. Taglialatela-Scafati, and D. Taramelli Activity against Plasmodium falciparum of cycloperoxyde compounds obtained from the sponge Plakortis simplex J. Antimicrob. Chemother. 50 2002 883 888 (Pubitemid 36032808)
22. M.T. Makler, J.M. Ries, J.A. Williams, J.E. Brancroft, R.C. Piper, B.L. Gibbins, and D.J. Hinrichs Parasite lactate dehydrogenase as an assay for Plamosdium falciparum drug sensitivity Am. J. Trop. Med. Hyg. 48 1993 739 741 (Pubitemid 23238452)
23. E. Lemos-Senna, D. Wouessidjewe, S. Lessieur, F. Puissieux, G. Couarraze, and D. Duchêne Evaluation of hydrophobic drug loading characteristics in nanoprecipited amphiphilic cyclodextrin nanospheres Pharm. Dev. Technol. 3 1 1998 85 94 (Pubitemid 28252508)
24. R.C. Rowe, P.J. Sheskey, M.E. Quinn, Handbook of Pharmaceutical Excipients, 6th ed., PhP, 917p.
25. B. Heurtault, P. Saulnier, B. Pech, J.-E. Proust, and J.-P. Benoit A novel phase inversion-based process for the preparation of lipid nanocarriers Pharm. Res. 19 6 2002 875 880 (Pubitemid 34692585)
26. F. Quaglia, L. Ostacolo, A. Mazzaglia, V. Villari, D. Zaccaria, and M.T. Sciortino The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs Biomaterials 30 2009 374 382
27. M. Teixeira, M.J. Alonso, M.M. Pinto, and C.M. Barbosa Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone Eur. J. Pharm. Biopharm. 59 2005 491 500 (Pubitemid 40347293)
28. A. Gze, L. Tieu Chau, L. Choisnard, J.P. Mathieu, D. Marti-Battle, L. Riou, J.-L. Putaux, and D. Wouessidjewe Biodistribution of intravenously administrated amphiphilic β-cyclodextrin nanospheres Int. J. Pharm. 344 1-2 2007 135 142 (Pubitemid 47495983)
29. A. Vonarbourg, C. Passirani, P. Saulnier, and J.-P. Benoit Parameters influencing the stealthiness of colloidal drug delivery systems Biomaterials 27 24 2006 4356 4373 (Pubitemid 43674179)
30. M. E Martinez-Barbosa, S. Cammas-Marion, L. Bouteiller, C. Vauthier, and G. Ponchel PEGylated degradable composite nanoparticles based on mixtures of PEG-b-poly(γ-benzyl l-glutamate) and poly(γ-benzyl l-glutamate) Bioconjugate Chem. 20 2009 1490 1496
31. N.T. Huynh, E. Roger, N. Lautram, J.-P. Benoît, and C. Passirani The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting Nanomedicine 5 9 2010 1415 1433
32. R. Grief, M. Luck, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blank, and R.H. Muller Stealth corona-core nanoparticles surface modified by polyethylene glycol (PEG): the influence of corona (PEG chain length and surface density) and the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf. B 18 2000 301 313 (Pubitemid 30479870)
33. S.M. Moghimi, and A.C. Hunter Capture of stealth nanoparticles by body's defences Crit. Rev. Ther. Drug Carrier Syst. 18 2001 527 550 (Pubitemid 34024395)
34. G.P. Zara, R. Cavalli, A. Bargoni, A. Fundaro, D. Vighetto, and M.R. Gasco Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues J. Drug Target. 10 4 2002 327 335 (Pubitemid 34746314)
35. L. Polato, L.M. Benedetti, L. Callegaro, and P. Couvreur In vitro evaluation of nanoparticle formulations containing gangliosides J. Drug Target. 2 1994 53 59 (Pubitemid 24106960)
36. Y. Cirpanli, E. Bilensoy, A.L. Dogan, and S. Calis Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery Eur. J. Pharm. Biopharm. 73 2009 82 89